Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7868]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
WCLC 2021: Durvalumab and tremelimumab with chemo improved PFS and OS in 1st-line stage IV NSCLC vs chemo
WCLC 2021: Durvalumab and tremelimumab with chemo improved PFS and OS in 1st-line stage IV NSCLC vs chemo
KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain
KRAS G12C inhibitor sotorasib receives conditional marketing authorisation by MHRA for use in Great Britain
FDA approves zanubrutinib for Waldenström’s macroglobulinemia
FDA approves zanubrutinib for Waldenström’s macroglobulinemia
Cancer treatment with built-in light
Cancer treatment with built-in light
Personalised cancer treatment tested on artificial cancer
Personalised cancer treatment tested on artificial cancer
When less is more: A modified chemotherapy regimen for a rare type of lymphoma
When less is more: A modified chemotherapy regimen for a rare type of lymphoma
Scientists research the new method of cancer treatment
Scientists research the new method of cancer treatment
Dual-action breast cancer compounds aim to overcome common drug-resistance issues
Dual-action breast cancer compounds aim to overcome common drug-resistance issues
A cost-effective anti-angiogenic drug to treat lung cancer is finally here
A cost-effective anti-angiogenic drug to treat lung cancer is finally here
Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway
Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation